Ziling Zeng

4.5k total citations · 6 hit papers
57 papers, 3.9k citations indexed

About

Ziling Zeng is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Ziling Zeng has authored 57 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Biomedical Engineering, 11 papers in Molecular Biology and 11 papers in Materials Chemistry. Recurrent topics in Ziling Zeng's work include Nanoplatforms for cancer theranostics (25 papers), Photodynamic Therapy Research Studies (8 papers) and Autoimmune Neurological Disorders and Treatments (6 papers). Ziling Zeng is often cited by papers focused on Nanoplatforms for cancer theranostics (25 papers), Photodynamic Therapy Research Studies (8 papers) and Autoimmune Neurological Disorders and Treatments (6 papers). Ziling Zeng collaborates with scholars based in China, Singapore and United States. Ziling Zeng's co-authors include Kanyi Pu, Jing Li, Chi Zhang, Yuyan Jiang, Shasha He, Jiaguo Huang, Si Si Liew, Chen Xie, Xin Wei and Dong Cui and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Advanced Materials.

In The Last Decade

Ziling Zeng

55 papers receiving 3.8k citations

Hit Papers

Semiconducting polymer nano-PROTACs for activatable photo... 2019 2026 2021 2023 2021 2019 2021 2022 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziling Zeng China 30 2.5k 1.3k 1.1k 589 468 57 3.9k
Ning Xu China 35 1.4k 0.6× 1.3k 1.0× 1.6k 1.4× 520 0.9× 255 0.5× 132 4.7k
Ying Ma United States 45 2.2k 0.9× 1.0k 0.8× 2.0k 1.7× 655 1.1× 465 1.0× 137 5.8k
Ying Tian China 42 1.9k 0.8× 1.2k 0.9× 2.7k 2.3× 1.0k 1.7× 351 0.8× 218 6.4k
Lei Rong China 30 1.6k 0.6× 680 0.5× 1.5k 1.3× 313 0.5× 276 0.6× 56 3.1k
Jin Woo Shin South Korea 22 2.4k 1.0× 1.6k 1.2× 763 0.7× 457 0.8× 124 0.3× 60 3.6k
Fanling Meng China 25 1.1k 0.5× 582 0.5× 1.0k 0.9× 294 0.5× 302 0.6× 57 2.8k
Lei Zhu China 40 2.0k 0.8× 1.1k 0.9× 1.4k 1.3× 439 0.7× 127 0.3× 92 4.3k
Xiyong Yu China 35 1.8k 0.7× 700 0.6× 2.3k 2.0× 599 1.0× 426 0.9× 132 4.6k
Fangyuan Zhou China 24 2.1k 0.9× 585 0.5× 1.2k 1.1× 580 1.0× 1.1k 2.4× 71 3.8k

Countries citing papers authored by Ziling Zeng

Since Specialization
Citations

This map shows the geographic impact of Ziling Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziling Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziling Zeng more than expected).

Fields of papers citing papers by Ziling Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziling Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziling Zeng. The network helps show where Ziling Zeng may publish in the future.

Co-authorship network of co-authors of Ziling Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Ziling Zeng. A scholar is included among the top collaborators of Ziling Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziling Zeng. Ziling Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Penghui, Ziling Zeng, Jing Liu, et al.. (2025). Urinary bioorthogonal reporters for the monitoring of the efficacy of chemotherapy for lung cancer and of associated kidney injury. Nature Biomedical Engineering. 9(5). 686–699. 16 indexed citations
2.
Zeng, Ziling, et al.. (2024). Clinical and pathological features of cerebrospinal meningitis caused by Pantoea agglomerans : a case report. BMC Infectious Diseases. 24(1). 1150–1150.
3.
Tang, Hongmei, Yun Zhang, Ziling Zeng, et al.. (2023). Astaxanthin attenuated cigarette smoke extract-induced apoptosis via decreasing oxidative DNA damage in airway epithelium. Biomedicine & Pharmacotherapy. 167. 115471–115471. 7 indexed citations
4.
Wang, Qiao, Linlin Guo, Ziling Zeng, et al.. (2023). Neferine Attenuates HDM-Induced Allergic Inflammation by Inhibiting the Activation of Dendritic Cell. Inflammation. 46(6). 2433–2448. 4 indexed citations
5.
Qu, Xiaobo, Ziling Zeng, Kai Wang, & Shuaian Wang. (2022). Replacing urban trucks via ground–air cooperation. SHILAP Revista de lepidopterología. 2. 100080–100080. 32 indexed citations
6.
Li, Jing, Yu Luo, Ziling Zeng, et al.. (2022). Precision cancer sono-immunotherapy using deep-tissue activatable semiconducting polymer immunomodulatory nanoparticles. Nature Communications. 13(1). 4032–4032. 141 indexed citations breakdown →
7.
Meng, Xin, Ziling Zeng, Shuai Guo, et al.. (2022). Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study. Neuropsychiatric Disease and Treatment. Volume 18. 953–964. 6 indexed citations
8.
Zhang, Chi, Jingsheng Huang, Ziling Zeng, et al.. (2022). Catalytical nano-immunocomplexes for remote-controlled sono-metabolic checkpoint trimodal cancer therapy. Nature Communications. 13(1). 3468–3468. 123 indexed citations breakdown →
9.
Yang, Mingwang, Ziling Zeng, Jacky W. Y. Lam, et al.. (2022). State-of-the-art self-luminescence: a win–win situation. Chemical Society Reviews. 51(21). 8815–8831. 79 indexed citations
10.
Wang, Tingting, Baojie Wang, Ziling Zeng, et al.. (2021). Efficacy and safety of bortezomib in rituximab-resistant anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis as well as the clinical characteristics: An observational study. Journal of Neuroimmunology. 354. 577527–577527. 17 indexed citations
11.
Wang, Ningning, Ziling Zeng, Baojie Wang, et al.. (2021). High serum creatinine is associated with reduction of psychiatric symptoms in female patients with anti-NMDAR encephalitis. Neuroscience Letters. 746. 135650–135650. 3 indexed citations
12.
Zeng, Ziling, Chunjuan Wang, Cuicui Liu, et al.. (2021). Follow-up of a Rickettsia felis encephalitis: Some new insights into clinical and imaging features. International Journal of Infectious Diseases. 104. 300–302. 5 indexed citations
13.
Zeng, Ziling, et al.. (2020). Clinical features of adult anti-N-methyl-d-aspartate receptor encephalitis after Japanese encephalitis. Journal of the Neurological Sciences. 417. 117080–117080. 7 indexed citations
14.
Wang, Chunjuan, Li Gong, Ziling Zeng, et al.. (2019). Genome-based analysis of SFTSV causing severe encephalitis with brain lesions. Journal of NeuroVirology. 26(2). 181–187. 10 indexed citations
15.
Zeng, Ziling, Chunjuan Wang, Baojie Wang, et al.. (2018). Prediction of neutrophil-to-lymphocyte ratio in the diagnosis and progression of autoimmune encephalitis. Neuroscience Letters. 694. 129–135. 44 indexed citations
16.
Zeng, Ziling, et al.. (2017). Trans-caryophyllene inhibits amyloid β (Aβ) oligomer-induced neuroinflammation in BV-2 microglial cells. International Immunopharmacology. 51. 91–98. 59 indexed citations
17.
Wang, Baojie, et al.. (2017). Lower dosages of rituximab used successfully in the treatment of anti-NMDA receptor encephalitis without tumour. Journal of the Neurological Sciences. 377. 127–132. 26 indexed citations
18.
Zeng, Ziling, et al.. (2017). Lower 25-Hydroxyvitamin D is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis. The journal of nutrition health & aging. 22(1). 38–43. 13 indexed citations
19.
Dong, Hongxin, Shirlene Wang, Ziling Zeng, et al.. (2014). Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice. Psychopharmacology. 231(24). 4711–4722. 38 indexed citations
20.
Yin, Qingqing, Yingjuan Ma, Hong Yan, et al.. (2014). Lycopene attenuates insulin signaling deficits, oxidative stress, neuroinflammation, and cognitive impairment in fructose-drinking insulin resistant rats. Neuropharmacology. 86. 389–396. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026